Predict your next investment

Corporation
ventura-biomed.com

See what CB Insights has to offer

Investments

1

About Ventura BioMed Investors

Ventura BioMed Investors invests in early-stage life science companies developing pioneering technologies and innovative therapies.

Ventura BioMed Investors Headquarter Location

Germany

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ventura BioMed Investors News

Abalos Therapeutics Raises €32.5M in Series A Extension

Oct 15, 2021

Abalos Therapeutics , a Dusseldorf, Germany-based company harnessing arenaviruses in a differentiated immuno-virotherapy approach to fight cancer, raised €32.5M in Series A extension round. This additional round, which brings the total raised to date to €43m (USD50m), was led by Seventure Partners with participation from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as existing investors including Boehringer Ingelheim Venture Fund (BIVF), Gründerfonds Ruhr, NRW.BANK and High-Tech Gründerfonds (HTGF). In conjunction with the closing of the Series A financing round extension, Annegret de Baey from Seventure Partners and Sebastian Pünzeler from Coparion will join Abalos’ Supervisory Board. The company intends to use the funds to advance its first product candidate into a Phase 1/2 trial in multiple solid tumors including the expansion cohorts to demonstrate early signs of clinical efficacy as well as fund further pipeline expansion. Led by Dr. Marcus Kostka, CEO, Abalos Therapeutics is advancing a technology platform that harnesses the unique features of the lymphocytic choriomeningitis virus (LCMV), which specifically targets tumor cells. Through its proprietary Fast Evolution Platform, the company is generating variants with optimized anti-tumoral properties to trigger a highly precise and directed immune response that can be utilized for distant metastases and enable long-term disease control. FinSMEs 15/10/2021

Ventura BioMed Investors Investments

1 Investments

Ventura BioMed Investors has made 1 investments. Their latest investment was in Abalos Therapeutics as part of their Series A - II on October 10, 2021.

CBI Logo

Ventura BioMed Investors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/14/2021

Series A - II

Abalos Therapeutics

$35.9M

Yes

3

Date

10/14/2021

Round

Series A - II

Company

Abalos Therapeutics

Amount

$35.9M

New?

Yes

Co-Investors

Sources

3

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.